Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR–Cas9 and ssODN in human cancer cellsZheng Hu, Yuan‐Shan Zhu|Cell & Bioscience|2018Cited by 84
LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast CancerYing Zeng, Yuan‐Shan Zhu, Chengfang Zhou et al.|Frontiers in Pharmacology|2019Cited by 26